One of the main advantages of next generation vectors is their reduced immunogenicity, which minimizes the risk of adverse immune reactions. Additionally, their ability to target specific cells or tissues reduces off-target effects and enhances the therapeutic index of the delivered agents. These vectors also offer controlled release properties, which can be crucial for maintaining therapeutic levels of a drug over time.
